iRhythm Technologies Soars on Morgan Stanley Upgrade
Update: 2025-12-22
Description
iRhythm Technologies stock surged by 3.4% following Morgan Stanleys price target increase, reflecting a positive outlook for the MedTech industry. Despite a slight pullback, shares closed at $181.68, marking a 4.3% gain from the previous close. The stock has been volatile, with twelve moves of over 5% in the last year. Year-to-date, iRhythm is up 103% and trading near its 52-week high. Despite a 1000$ investment from five years ago being worth $776 today, analysts remain bullish, positioning iRhythm for more attention as the MedTech sector heats up.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
